Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

Recruiting N/A Interventional Study
Placenta Accreta Spectrum
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
15 (estimated)
Sponsor
University of Pennsylvania · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire u…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. A person with a uterus, age 18 or older 4. Currently pregnant with an intrauterine gestation or postpartum 5. Susp…
Contacts

Beth Pineles, MD Phd

267-226-7933

beth.pineles@pennmedicine.upenn.edu

CONTACT

Meaghan McCabe, MPH

meaghan.mccabe@pennmedicine.upenn.edu

CONTACT